Skip to main content
Premium Trial:

Request an Annual Quote

They Came Up With the Acronym First, Right?

The National Institutes of Health announced a new initiative in collaboration with the National Science Foundation and the White House Office of Science and Technology Policy that "promises to monitor the impact of federal science investments on employment, knowledge generation, and health outcomes." The Science and Technology for America's Reinvestment: Measuring the Effect of Research on Innovation, Competitiveness, and Science — or STAR METRICS — initiative is being funded $1 million in its first year to collect voluntary data from participating institutions. "Information will be gathered from the universities in a highly automated way, with minimal or no burden for the scientists and the university administration," according to the NIH announcement. The first phase of the program will use institutional records to measure the "employment impact of federal science spending," while the second will calculate the impact in the areas of economic growth, workforce outcomes, scientific knowledge — through publications and citations — and social outcomes, according to NIH.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.